What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the price band for Nidan Laboratories and Healthcare Limited IPO?

The price band for Nidan Laboratories and Healthcare Limited IPO is set at ₹125 to ₹125 per equity share with a minimum lot size of 1000 shares.

When does Nidan Laboratories and Healthcare Limited IPO open and close?

The Nidan Laboratories and Healthcare Limited IPO opens on 2021-10-28 and closes on 2021-11-02. The allotment date is 2021-11-09 and the listing date is 2021-11-12.

What is the current GMP of Nidan Laboratories and Healthcare Limited IPO?

The current grey market premium (GMP) for Nidan Laboratories and Healthcare Limited IPO is ₹0, implying an estimated listing price of ₹125 (0% gain over the upper price band).

How do I check Nidan Laboratories and Healthcare Limited IPO allotment status?

You can check the allotment status on the registrar's official portal (Bigshare Services Private Limited) or through the BSE/NSE allotment websites once the basis of allotment is finalized.

Nidan Laboratories and Healthcare Limited

ListedSME

Healthcare · NSE

Incorporated in 2000, Nidan Laboratories and Healthcare Limited provides a wide range of diagnostic services including pathology, radiology, neurology, cardiology, and dental care. The company offers hundreds of routine and specialized pathology and radiology tests, covering everything from basic blood tests and X-rays to advanced molecular diagnostics, CT scans, and MRI scans, along with customized health packages and services like home sample collection and digital report delivery. Nidan operates diagnostic and collection centers under its brand, supported by its own appointment-booking mobile app and management software, partners with established pathology labs, employs over 200 people, and has received industry recognition for its diagnostic services.

Price Band

₹125

Issue Size

₹50.00 Cr

Lot Size

1000 shares

GMP

—

Est. Listing

₹125

at current GMP

Subscribed

—

Open

28 Oct 2021

2 Nov 2021

Allotment

9 Nov 2021

Refund

10 Nov 2021

Demat Credit

11 Nov 2021

Listing

12 Nov 2021

Last updated 12 days ago

Overview GMP Subscription Financials IPO Details Company Promoters Objects Peers Documents Allotment FAQs

Key Highlights

•Leading player in the Healthcare segment
•Price band established at ₹125 - ₹125 per equity share
•Minimum bid lot is 1000 shares
•Estimated listing target of ₹125 based on current grey market activity